Why Astrana Health, Inc.’s (ASTH) Stock Is Down 6.13%
As of Tuesday, November 10, Astrana Health, Inc.’s ASTH share price has dipped by 6.13%, which has investors questioning if this is right time to buy.Michael Rose
Stock Evaluator: Astrana Health, Inc. (ASTH)
Astrana Health, Inc. ASTH
$31.77
-1.17
-3.55%
November 12, 2026 4:00:00 PM
EST
Volume: 334,729
After Hours: $120.37
0.15
|
0.12%
November 10, 2021 7:59 PM
EST
Volume: 72,713
USD
NASD | DELAYED PRICE
| SECTOR | INDUSTRY |
| Health Care | Health Care Providers & Services |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Astrana Health, Inc., a healthcare management company, provides medical care services in the United States. The company operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. Its physician network includes primary care physicians, specialist physicians and extenders, and hospitalists. The company serves patients primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization; and non-insured patients. The company was formerly known as Apollo Medical Holdings, Inc. and changed its name to Astrana Health, Inc. in February 2024. Astrana Health, Inc. was founded in 1992 and is headquartered in Alhambra, California.
Commentary & Analysis
Why Astrana Health, Inc.’s (ASTH) Stock Is Down 10.86%
As of Friday, November 06, Astrana Health, Inc.’s ASTH share price has dipped by 10.86%, which has investors questioning if this is right time to buy.Rosalio Madrigal
What You Need to Know About Astrana Health, Inc.'s Q4 Earnings
Astrana Health, Inc.'s fiscal Q4 earnings report was released on Thursday, November 05. Let's dive in to see if (ASTH) missed or beat analyst's expectations.Rosalio Madrigal
Why Astrana Health, Inc.’s (ASTH) Stock Is Up 8.30%
As of Wednesday, November 04, Astrana Health, Inc.’s ASTH share price has surged by 8.30%, which has investors questioning if this is right time to sell.Jenna Brashear
Why Astrana Health, Inc.’s (ASTH) Stock Is Down 6.58%
As of Wednesday, September 23, Astrana Health, Inc.’s ASTH share price has dipped by 6.58%, which has investors questioning if this is right time to buy.Rosalio Madrigal
Financial Summary
| Share Statistics | ASTH | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $1,686.8 | $1,928.3 | 52% |
|
| Shares Out (Mil) | 49.9 | 80.2 | 48% |
|
| Institutional Ownership | 85.6% | 86.0% | 53% |
|
| Float (Mil) | 45.7 | 58.8 | 45% |
|
| Beta | 1.24 | 0.69 | 72% |
|
| Avg Daily Volume (000s) | 471 | 773 | 56% |
|
| Price Change (52-week) |
46.9% | 83.4% | 84% |
|
| Growth | ASTH | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 35.9% | 10.3% | 92% |
|
| Net Income (5yr) | (9.8%) | (0.7%) | 29% |
|
| EPS (5yr) | (14.6%) | 2.1% | 19 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | 3.7% | (17.4%) | 66% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 3 | 3 | 3 | |
| Current EPS | $0.617 | $2.970 | $3.487 | |
| Month Ago EPS | $0.650 | $3.067 | $3.637 | |
| # Rev Up | 1 | 1 | 1 | |
| # Rev Down | 0 | 0 | 0 | |
| Three Months Ago EPS | $0.640 | $3.040 | $3.540 | |
| Year/Year Chg | 137.3% | 548.5% | 798.5% | |
| Financials | ASTH | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $3,912 | $1,505 | 70% |
|
| Net Income (TTM) (Mil) | $53 | $30 | 55% |
|
| EPS (TTM) | $1.081 | $0.300 | 61% |
|
| Operating Cash Flow (TTM) (Mil) | $114 | $167 | 53% |
|
| Net Cash Flow (TTM) (Mil) | ($63) | $4 | 19% |
|
| Long-Term Debt (Q1) (Mil) | $907 | $421 | 65% |
|
| Enterprise Value (Q1) (Mil) | $2,123 | $2,396 | 50% |
|
| Valuation | ASTH | Industry Median |
Percentile (All Stocks) |
|
| P/B | 1.90 | 2.98 | 52% |
|
| P/E | 30.5 | 27.7 | 72% |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 1.2 | na |
|
| Ratios | ASTH | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 11.0% | 27.9% | 10% |
|
| Net Margin | 1.4% | 1.4% | 35% |
|
| ROA | 2.3% | 2.4% | 57% |
|
| ROE | 6.5% | 7.5% | 46% |
|
| Liabilities to Assets | 73.1% | 61.9% | 69% |
|
| F-Score | 7 | 5 | 82% |
|
Astrana Health, Inc. did not pass any screens on 11/11/2026.
